Contraceptive Game Changer: How Patients Can Benefit From the OTC Birth Control Pill

Family physician Montida Fleming, MD, who played a role in norgestrel (Opill)'s road to FDA approval, presents what providers need to know about this soon-to-be-available option, from mechanisms of action to the data on efficacy and safety. She also discusses Opill's advantages in a world where patients face numerous barriers to prescription contraceptives and in a political climate that has made reliable methods more crucial than ever. Hear her thoughts on how medical professionals can help ensure equitable access for patients of all ages, gender identities, income levels and personal circumstances.


January 30, 2024

Created by

UCSF MedConnection

Related Presenters

Mai Fleming, MD

Mai Fleming, MD

MSP Staff Physician, Family Community Medicine

View full profile